logo

ASMB

Assembly Biosciences·NASDAQ
--
--(--)
--
--(--)
4.54 / 10
Netural

The security demonstrates modest fundamental health (4.5/10). Positive indicators: Interest coverage ratio (EBIT / Interest expense) (%) and Revenue-MV, despite concerns regarding PB-ROE and Days sales outstanding. Analytical conclusion: moderate.

Fundamental(4.54)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.16
Score3/3
Weight17.37%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value40.97
Score2/3
Weight1.48%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-1.91%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.85%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.86%
1M Return8.45%
PB-ROE
Value-0.25
Score1/3
Weight16.86%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.39%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value40.97
Score2/3
Weight0.57%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.68%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.62%
1M Return8.41%
Is ASMB fundamentally strong?
  • ASMB scores 4.54/10 on fundamentals and holds a Fair valuation at present. Backed by its -26.12% ROE, -103.65% net margin, -10.64 P/E ratio, 2.27 P/B ratio, and 33.24% earnings growth, these metrics solidify its Netural investment rating.